NuCana Analyst Ratings
NuCana Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/18/2023 | 412.82% | Oppenheimer | → $4 | Reiterates | Outperform → Outperform |
| 05/22/2023 | 412.82% | Oppenheimer | → $4 | Reiterates | Outperform → Outperform |
| 09/22/2022 | 284.62% | Jefferies | $21 → $3 | Maintains | Buy |
| 03/03/2022 | — | Cowen & Co. | Downgrades | Outperform → Market Perform | |
| 11/24/2021 | 1053.85% | HC Wainwright & Co. | $10 → $9 | Maintains | Buy |
| 12/01/2020 | 1182.05% | HC Wainwright & Co. | $15 → $10 | Maintains | Buy |
| 11/24/2020 | 1823.08% | HC Wainwright & Co. | $17 → $15 | Maintains | Buy |
| 10/22/2020 | 2720.51% | Truist Securities | → $22 | Initiates Coverage On | → Buy |
| 08/21/2020 | 2079.49% | HC Wainwright & Co. | $16 → $17 | Maintains | Buy |
| 07/24/2020 | 2464.1% | Oppenheimer | → $20 | Initiates Coverage On | → Outperform |
| 03/11/2020 | 1951.28% | HC Wainwright & Co. | $17 → $16 | Maintains | Buy |
| 11/15/2019 | 2079.49% | HC Wainwright & Co. | $20 → $17 | Reiterates | → Buy |
| 08/19/2019 | 2464.1% | HC Wainwright & Co. | → $20 | Initiates Coverage On | → Buy |
| 10/19/2018 | 4515.38% | Piper Sandler | → $36 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 08/18/2023 | 412.82% | 奥本海默 | → 4 美元 | 重申 | 跑赢大盘 → 跑赢大盘 |
| 05/22/2023 | 412.82% | 奥本海默 | → 4 美元 | 重申 | 跑赢大盘 → 跑赢大盘 |
| 2022 年 9 月 22 日 | 284.62% | 杰富瑞 | 21 美元 → 3 美元 | 维护 | 购买 |
| 2022 年 3 月 3 日 | — | Cowen & Co. | 降级 | 跑赢大盘 → 市场表现 | |
| 11/24/2021 | 1053.85% | HC Wainwright & Co. | 10 美元 → 9 美元 | 维护 | 购买 |
| 12/01/2020 | 1182.05% | HC Wainwright & Co. | 15 美元 → 10 美元 | 维护 | 购买 |
| 11/24/2020 | 1823.08% | HC Wainwright & Co. | 17 美元 → 15 美元 | 维护 | 购买 |
| 2020 年 10 月 22 日 | 2720.51% | 信托证券 | → 22 美元 | 启动覆盖开启 | → 购买 |
| 08/21/2020 | 2079.49% | HC Wainwright & Co. | 16 美元 → 17 美元 | 维护 | 购买 |
| 2020 年 7 月 24 日 | 2464.1% | 奥本海默 | → 20 美元 | 启动覆盖开启 | → 跑赢大盘 |
| 03/11/2020 | 1951.28% | HC Wainwright & Co. | 17 美元 → 16 美元 | 维护 | 购买 |
| 11/15/2019 | 2079.49% | HC Wainwright & Co. | 20 美元 → 17 美元 | 重申 | → 购买 |
| 08/19/2019 | 2464.1% | HC Wainwright & Co. | → 20 美元 | 启动覆盖开启 | → 购买 |
| 2018 年 10 月 19 日 | 4515.38% | 派珀·桑德勒 | → 36 美元 | 启动覆盖开启 | → 超重 |
What is the target price for NuCana (NCNA)?
NuCana（NCNA）的目标价格是多少？
The latest price target for NuCana (NASDAQ: NCNA) was reported by Oppenheimer on August 18, 2023. The analyst firm set a price target for $4.00 expecting NCNA to rise to within 12 months (a possible 412.82% upside). 3 analyst firms have reported ratings in the last year.
奥本海默于2023年8月18日公布了NuCana（纳斯达克股票代码：NCNA）的最新目标股价。该分析公司将目标股价定为4.00美元，预计NCNA将在12个月内上涨至412.82％（可能上涨412.82％）。去年有3家分析公司公布了评级。
What is the most recent analyst rating for NuCana (NCNA)?
NuCana (NCNA) 的最新分析师评级是多少？
The latest analyst rating for NuCana (NASDAQ: NCNA) was provided by Oppenheimer, and NuCana reiterated their outperform rating.
NuCana（纳斯达克股票代码：NCNA）的最新分析师评级由奥本海默提供，NuCana重申了其跑赢大盘的评级。
When is the next analyst rating going to be posted or updated for NuCana (NCNA)?
NuCana（NCNA）的下一次分析师评级何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NuCana, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NuCana was filed on August 18, 2023 so you should expect the next rating to be made available sometime around August 18, 2024.
分析师在进行了广泛的研究后得出了股票评级，包括阅读公开财务报表、与NuCana的高管和客户交谈以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应获得4个评级。NuCana的最新评级是在2023年8月18日提交的，因此你应该预计下一个评级将在2024年8月18日左右公布。
Is the Analyst Rating NuCana (NCNA) correct?
NuCana（NCNA）的分析师评级是否正确？
While ratings are subjective and will change, the latest NuCana (NCNA) rating was a reiterated with a price target of $0.00 to $4.00. The current price NuCana (NCNA) is trading at is $0.78, which is within the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但重申了最新的NuCana（NCNA）评级，目标股价为0.00美元至4.00美元。NuCana（NCNA）目前的交易价格为0.78美元，在分析师的预测区间内。